Navigation Links
Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc.

Poway, CA (PRWEB) July 10, 2014

Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., the leading Regenerative Veterinary Medicine company, is proud to announce the relaunch of his highly informative blog, now named Stem Cells for Pets, launching with a new series called “What are Stem Cells?” Dr. Harman’s purpose for blogging is to give an honest and straightforward foundation in the basics of stem cell therapy so that pet owners can make an educated decision on the right type of treatment when considering regenerative medicine.

A veterinarian by trade, Dr. Harman is in his third decade of biotechnology entrepreneurial-ship, has overseen the completion of more than a thousand contract research projects in veterinary and human products, and has led a handful of companies to licensing and sale. Harman’s current company, Vet-Stem, was the first to provide an adipose-derived stem cell service to veterinarians for their patients. As a pioneer in the field, Vet-Stem now holds exclusive licenses to over 50 patents, and continues blazing the trail for clinical trials and scientific studies.

Dr. Harman leverages this experience and Vet-Stem’s over 10,000 horse, dog, cat, and exotic animal cases in the last decade to present supporting data, not only for orthopedic conditions, but also on the use of stem cells for various degenerative, immune-mediated, inflammatory, and organ diseases. He has authored several book chapters, created a stem cell RACE (Registry of Approved Continuing Education for the American Association of Veterinary State Boards) Continuing Education course for veterinarians and technicians, and is currently developing a curriculum for a Regenerative Veterinary Medicine college course. All the while he truly enjoys communicating with interest groups and pet owners about cutting-edge medicine for their animals.

Dr. Harman speaks with agility groups, working dog clubs, performance horse gatherings, and at industry conferences with the desire of spreading the facts about the positive capabilities of stem cells. He will be using his new blog, Stem Cells for Pets, as a public forum for pet owners to read about basic topics explaining where stem cells come from, how they work and their capabilities; as well as what stem cells are currently being used to treat, what to expect from the treatment, and alternative therapies that can be partnered with stem cell therapy for advanced improvement.

In small animal health care more and more pet owners are educating themselves on breed specific ailments and diseases. This is also an area of interest for Dr. Harman, who is committed to investigating and reporting of stem cell therapy for alternative uses such as chronic kidney failure in cats and inflammatory bowel disease in dogs. Although Vet-Stem Cell Therapy was originally created for acute injuries in horses, like bowed tendons and torn ligaments, Vet-Stem’s mission is to improve the lives of all animals through regenerative medicine.

About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit or call 858-748-2004.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
2. Robert Farrell Joins Bionovos Board of Directors
3. Engineer Robert J. Wood to receive NSFs Alan T. Waterman Award
4. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
5. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
6. Robert Haynes To Lead Licensing As VR Laboratories Senior Vice President Product Introduction And Licensing
7. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
8. Robert Storey Joins VIC Technology Venture Development as Executive in Residence
9. Roberto DellOro Named Director of LMUs Bioethics Institute
10. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):